Pancreas Tx Basics - Grafts & Samples
- Goal: Achieve insulin independence in select diabetes patients.
⭐ Most common indication for pancreas transplant is type 1 diabetes mellitus with end-stage renal disease, often as a simultaneous pancreas-kidney (SPK) transplant.
- Graft Sources: Deceased donor. Whole pancreas, typically with a duodenal segment for exocrine drainage.
- Common Transplant Types:
- Simultaneous Pancreas-Kidney (SPK): Most frequent.
- Pancreas Transplant Alone (PTA)
- Pancreas After Kidney (PAK)
- Monitoring & Diagnosis:
- Biopsy: Gold standard for rejection diagnosis. Usually image-guided percutaneous.
- Samples: Pancreatic parenchyma; duodenal cuff (if present) for enteric drainage monitoring.
oka
Rejection Realms - Immune Attack!
Pancreas allograft rejection: major cause of graft dysfunction. Biopsy is crucial for diagnosis and grading.
-
Key Rejection Types:
- Acute Cellular Rejection (ACR): T-cell mediated.
- Antibody-Mediated Rejection (AMR): Antibody (Donor-Specific Antibodies - DSA) mediated.
- Chronic Active Rejection: Ongoing immune injury leading to fibrosis.
-
ACR vs. AMR Features (Banff Criteria):
Feature Acute Cellular Rejection (ACR) Antibody-Mediated Rejection (AMR) Primary Mediator T-lymphocytes Donor-Specific Antibodies (DSA) & Complement Key Histo Endothelialitis (venulitis v score), ductitis/acinar inflammation (t score), septal inflammation Capillaritis (interacinar/periductal ptc score), arteritis (ah score), microvascular thrombosis IHC T-cell infiltrates (CD3+) C4d deposition in capillaries (key marker) Banff Grade (ACR) Grade I (Mild), II (Moderate), III (Severe) based on v, t, i scores. Diagnosed by: Histologic evidence + C4d + DSA (or strong suspicion for DSA) -
Chronic Rejection:
- Irreversible, progressive graft fibrosis, atrophy, and vascular intimal thickening (graft arteriosclerosis). Leads to exocrine/endocrine failure.
⭐
C4d deposition in peritubular/interacinar capillaries is a key immunohistochemical marker for antibody-mediated rejection in pancreatic allografts.

- Simplified Diagnostic Approach:
Pesky Pathogens - Infection Invasion
- Immunosuppression predisposes to opportunistic infections.
- Common pathogens:
- CMV: Major threat; causes pancreatitis, duodenitis, systemic disease.
- Fungi: Candida, Aspergillus (invasive disease).
- Bacteria: Often polymicrobial; gut-derived.
- Clinical signs: Fever, graft tenderness, ↑ amylase/lipase.
- Diagnosis: Biopsy (look for viral inclusions, hyphae), cultures, PCR.

⭐ CMV infection is a significant concern in pancreas transplant recipients and can manifest as graft pancreatitis or systemic illness.
Other Complications - Trouble Triangle
- Vascular Catastrophes:
- Graft thrombosis (arterial/venous): Critical early event. Acute hyperglycemia, ↓C-peptide.
⭐ Graft thrombosis (arterial or venous) is a devastating complication, often leading to early graft loss, especially in the immediate post-operative period.
- Hemorrhage: Significant intra-abdominal/GI bleeding. Life-threatening.
- Graft thrombosis (arterial/venous): Critical early event. Acute hyperglycemia, ↓C-peptide.
- Parenchymal & Anastomotic Failure:
- Graft pancreatitis: Ischemia-reperfusion, surgical handling. Pain, ↑serum amylase/lipase.
- Anastomotic leaks (enteric/vascular): Risk of sepsis, abscess, fistula. High morbidity.
- Immunosuppression-Related:
- PTLD (Post-Transplant Lymphoproliferative Disorder): EBV-driven; linked to overall immunosuppression.
oka
- PTLD (Post-Transplant Lymphoproliferative Disorder): EBV-driven; linked to overall immunosuppression.
High‑Yield Points - ⚡ Biggest Takeaways
- Acute cellular rejection (ACR) is the most common cause of early graft dysfunction, primarily T-cell mediated.
- Chronic rejection is characterized by graft arteriosclerosis, islet cell loss, and fibrosis.
- Antibody-mediated rejection (AMR) is identified by C4d deposition in peritubular and interacinar capillaries.
- Cytomegalovirus (CMV) is a frequent opportunistic infection causing graft pancreatitis or duodenitis.
- Post-Transplant Lymphoproliferative Disorder (PTLD), often EBV-associated, is a critical complication.
- Allograft biopsy is the gold standard for diagnosing rejection and other pathologies.
- Recurrence of autoimmune diabetes can occur in the pancreatic allograft over time.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app